Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
BASECLICK GMBH is currently managing a patent portfolio within the Biotechnology & Pharmaceuticals technology area. The company has 2 pending office actions currently on its docket. These actions are being reviewed by 2 distinct examiners, which indicates that the company's immediate prosecution workload is distributed across multiple officials. This distribution requires a legal strategy that can account for the different review styles of the 2 distinct examiners involved.
The busiest examiner for this portfolio is SHIN, DANA H, who is responsible for 1 busiest examiner pending action. This examiner handles a portion of the 2 pending office actions currently active. Furthermore, the prosecution is spread across 2 distinct art units. This suggests that the company's current intellectual property efforts span multiple technical niches within the biotechnology and pharmaceuticals field, requiring expertise to navigate the examination process across different administrative units.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (50%) |
| No statute on record | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| SHIN, DANA H | 1 | 27.0% | +27.0% |
| PARISI, JESSICA DANIELLE | 1 | 75.8% | +32.3% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17912402 | MODIFIED MRNAS FOR VACCINE DEVELOPMENT | SHIN, DANA H | 15d overdue |
| 17639743 | METHOD OF AMPLIFYING MRNAS AND FOR PREPARING FULL LENGTH MRNA LIBRARIES | PARISI, JESSICA DANIELLE | 26d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17912402 | MODIFIED MRNAS FOR VACCINE DEVELOPMENT | SHIN, DANA H | 15d overdue |
| 17639743 | METHOD OF AMPLIFYING MRNAS AND FOR PREPARING FULL LENGTH MRNA LIBRARIES | PARISI, JESSICA DANIELLE | 26d |
| Art Unit | Apps |
|---|---|
| 1635 | 1 |
| 1684 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17912402 | MODIFIED MRNAS FOR VACCINE DEVELOPMENT | SHIN, DANA H | 1635 | Other | Final Rejection | 15d overdue | Pending | Sep 16, 2022 |
| 17639743 | METHOD OF AMPLIFYING MRNAS AND FOR PREPARING FULL LENGTH MRNA LIBRARIES | PARISI, JESSICA DANIELLE | 1684 | §103§112 | Final Rejection | 26d | Pending | Mar 02, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial